Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Vanda Pharmaceuticals Inc
Total Other Income
Vanda Pharmaceuticals Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
|
Total Other Income
$21.3m
|
CAGR 3-Years
89%
|
CAGR 5-Years
37%
|
CAGR 10-Years
64%
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$3.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-78%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$158m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$55.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vanda Pharmaceuticals Inc's Total Other Income?
Total Other Income
21.3m
USD
Based on the financial report for Mar 31, 2024, Vanda Pharmaceuticals Inc's Total Other Income amounts to 21.3m USD.
What is Vanda Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
64%
Over the last year, the Total Other Income growth was 155%. The average annual Total Other Income growth rates for Vanda Pharmaceuticals Inc have been 89% over the past three years , 37% over the past five years , and 64% over the past ten years .